J. Weiss

1.6k total citations · 1 hit paper
8 papers, 1.2k citations indexed

About

J. Weiss is a scholar working on Oncology, Surgery and Cell Biology. According to data from OpenAlex, J. Weiss has authored 8 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Surgery and 2 papers in Cell Biology. Recurrent topics in J. Weiss's work include Lymphatic System and Diseases (6 papers), Diagnosis and Treatment of Venous Diseases (2 papers) and Myofascial pain diagnosis and treatment (2 papers). J. Weiss is often cited by papers focused on Lymphatic System and Diseases (6 papers), Diagnosis and Treatment of Venous Diseases (2 papers) and Myofascial pain diagnosis and treatment (2 papers). J. Weiss collaborates with scholars based in United States, Iran and Switzerland. J. Weiss's co-authors include Steinar Aamdal, Jonathan Cebon, Amy V. Kapp, N. Thatcher, Dirk Schadendorf, Jean‐Jacques Grob, Uwe Fraass, Simone Seiter, A. Coates and Brigitte Dréno and has published in prestigious journals such as Journal of Clinical Oncology, Physical Therapy and PubMed.

In The Last Decade

J. Weiss

8 papers receiving 1.1k citations

Hit Papers

Randomized Phase III Study of Temozolomide Versus Dacarba... 2000 2026 2008 2017 2000 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Weiss United States 8 912 550 243 152 141 8 1.2k
Uwe Fraass Germany 6 709 0.8× 589 1.1× 258 1.1× 83 0.5× 169 1.2× 13 1.1k
M. Thomas France 8 758 0.8× 503 0.9× 238 1.0× 48 0.3× 172 1.2× 20 1.1k
Lorenza Di Guardo Italy 15 987 1.1× 360 0.7× 398 1.6× 76 0.5× 248 1.8× 48 1.2k
Lucia Festino Italy 18 880 1.0× 368 0.7× 375 1.5× 99 0.7× 190 1.3× 39 1.2k
Andrea E. Wahner Hendrickson United States 15 839 0.9× 633 1.2× 164 0.7× 64 0.4× 127 0.9× 55 1.3k
Vijay Peddareddigari United States 11 600 0.7× 714 1.3× 111 0.5× 149 1.0× 183 1.3× 18 1.2k
Vito Vanella Italy 16 709 0.8× 328 0.6× 267 1.1× 86 0.6× 145 1.0× 34 997
K. Papadopoulos United States 16 540 0.6× 598 1.1× 299 1.2× 55 0.4× 215 1.5× 56 1.1k
Vanja Vaccaro Italy 15 780 0.9× 491 0.9× 188 0.8× 124 0.8× 312 2.2× 30 1.2k
Jianghua Zheng China 13 636 0.7× 515 0.9× 353 1.5× 69 0.5× 150 1.1× 40 1.2k

Countries citing papers authored by J. Weiss

Since Specialization
Citations

This map shows the geographic impact of J. Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Weiss more than expected).

Fields of papers citing papers by J. Weiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Weiss. The network helps show where J. Weiss may publish in the future.

Co-authorship network of co-authors of J. Weiss

This figure shows the co-authorship network connecting the top 25 collaborators of J. Weiss. A scholar is included among the top collaborators of J. Weiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Weiss. J. Weiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Weiss, J., et al.. (2015). VALIDATION OF THE LYMPHEDEMA LIFE IMPACT SCALE (LLIS): A CONDITION-SPECIFIC MEASUREMENT TOOL FOR PERSONS WITH LYMPHEDEMA.. PubMed. 48(3). 128–38. 52 indexed citations
2.
Haghighat, Shahpar, et al.. (2013). Predictive factors of response to phase I complete decongestive therapy in upper extremity lymphedema following breast carcinoma in Iran.. PubMed. 46(2). 97–104. 20 indexed citations
3.
Deng, Jie, Mei R. Fu, Jane M. Armer, et al.. (2013). Self-reported information sources and perceived knowledge in individuals with lymphedema.. PubMed. 46(4). 173–83. 10 indexed citations
4.
Ridner, Sheila H., Jie Deng, Mei R. Fu, et al.. (2012). Symptom burden and infection occurrence among individuals with extremity lymphedema.. PubMed. 45(3). 113–23. 37 indexed citations
5.
Haghighat, Shahpar, et al.. (2010). Comparing two treatment methods for post mastectomy lymphedema: complex decongestive therapy alone and in combination with intermittent pneumatic compression.. PubMed. 43(1). 25–33. 49 indexed citations
6.
Weiss, J. & Beverly J. Spray. (2002). The effect of complete decongestive therapy on the quality of life of patients with peripheral lymphedema.. PubMed. 35(2). 46–58. 67 indexed citations
7.
Middleton, Mark R., Jean‐Jacques Grob, Neil K. Aaronson, et al.. (2000). Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma. Journal of Clinical Oncology. 18(1). 158–158. 936 indexed citations breakdown →
8.
Weiss, J.. (1998). Treatment of Leg Edema and Wounds in a Patient With Severe Musculoskeletal Injuries. Physical Therapy. 78(10). 1104–1113. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026